China Health Group Limited reported progress on actions taken to address the auditors’ disclaimer of opinion regarding the Company’s going concern status for the year ended 31 March 2025. The Board highlighted plans to improve liquidity, including a subscription agreement that was expected to raise gross proceeds of around HK$70.0 million and a proposed rights issue aiming to raise an estimated HK$15.0 million.

According to the announcement, both the subscription and rights issue, completed on 6 October 2025, brought in approximately HK$80.9 million in net proceeds. Negotiations with the bank to renew a HK$5.4 million borrowing are anticipated to conclude by the end of the first quarter of 2026. The Board also remains open to seeking further funding through various channels if needed.

The Company plans to publish additional updates by 23 January 2026 and every three months thereafter until the disclaimer of opinion is resolved. Shareholders and investors are advised to exercise caution when dealing in the Company’s securities.